This eLearning module has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice and Guidelines Learning. Products are discussed.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104397 April 2021
Checklist on the implementation of the NICE guideline on atrial fibrillation: diagnosis and management
This implementation checklist has been commissioned and funded by Daiichi Sankyo UK and developed in partnership with Guidelines in Practice.
View LIXIANA (edoxaban) prescribing and adverse event reporting information
EDX/21/0535 July 2021
Improving outcomes in the management of patients with chronic coronary syndrome and stable anginal chest pain for the acute and general physician
Information intended for UK healthcare professionals only.
This promotional supplement has been commissioned and funded by A. Menarini Farmaceutica Internazionale SRL and developed in partnership with Guidelines in Practice.
View Ranexa (ranolazine) prescribing information and adverse event reporting information here
Date of preparation: July 2021
NICE Technology Appraisal 694: Bempedoic acid▼ with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
The production of this Guidelines card has been commissioned and funded by Daiichi Sankyo UK.
View Bempedoic acid (Nilemdo®▼) & Bempedoic acid and ezetimibe (Nustendi®▼) prescribing and adverse event reporting information
BEM/21/0374 May 2021
A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
A clear summary of NICE’s guideline on atrial fibrillation management
A summary of recommendations for advising patients and the public on managing venous disease